Expanding Seniors’ Access to PFAS Testing Act

HR 5571, the "Expanding Seniors’ Access to PFAS Testing Act," requires Medicare to cover 100% of the cost for blood tests detecting PFAS chemicals (perfluoroalkyl and polyfluoroalkyl substances) for seniors starting January 1, 2028. It amends Medicare law to add "PFAS testing" as a no-cost preventive service under Part B, defined as a physician-ordered blood test to measure PFAS levels. This directly affects Medicare beneficiaries aged 65+ and certain disabled individuals who need these tests. The coverage eliminates copays and deductibles for the tests, aligning them with other preventive services, but applies only to tests performed on or after the 2028 effective date.